ENTITY
CSPC Pharmaceutical Group

CSPC Pharmaceutical Group (1093 HK)

247
Analysis
Health CareChina
CSPC Pharmaceutical Group Limited, through its subsidiaries, manufactures and sells pharmaceutical products. The Company's products include vitamin C, antibiotics and common generic drugs. The Company is also engages in the development of innovative drugs and antibiotics.
more
25 Aug 2023 07:42Broker

CSPC Pharmaceutical (1093 HK) – Steady Finished Drug Sales

The adjusted attributable net profit (excl. impact from fair value change of financial assets and share-based compensation) in 1H23 increased 3.0%...

Logo
338 Views
Share
30 May 2023 01:11Broker

CSPC Pharmaceutical (1093 HK) – To further expand mRNA and ADC pipelines

The 1Q23 sales of finished drugs increased 1.9% YoY to RMB6.42bn, with the nervous system disease products recording +9.8% YoY sales growth, driven...

Logo
234 Views
Share
24 Mar 2023 04:57Broker

CSPC Pharmaceutical (1093 HK) – mRNA platform verified with product approval

CSPC reported FY22 revenue of RMB30.94bn (+11.0% YoY) and attributable net profit of RMB6.09bn (+8.7% YoY), in line with our estimates of...

Logo
429 Views
Share
24 Nov 2022 09:04Broker

CSPC Pharmaceutical (1093 HK) – Promising clinical progress of mRNA COVID-19 vaccine candidate

CSPC reported 9M22 revenue of RMB23.5bn, up by 13.8% YoY (+15.6% YoY for 3Q22), and attributable net profit of RMB4.5bn, up by 3.1% YoY

Logo
291 Views
Share
x